BR9911885A - Angiogenesis inhibitors - Google Patents
Angiogenesis inhibitorsInfo
- Publication number
- BR9911885A BR9911885A BR9911885-8A BR9911885A BR9911885A BR 9911885 A BR9911885 A BR 9911885A BR 9911885 A BR9911885 A BR 9911885A BR 9911885 A BR9911885 A BR 9911885A
- Authority
- BR
- Brazil
- Prior art keywords
- angiogenesis inhibitors
- angiogenesis
- inhibitors
- aryl
- antagonists
- Prior art date
Links
- 229940121369 angiogenesis inhibitor Drugs 0.000 title abstract 2
- 239000004037 angiogenesis inhibitor Substances 0.000 title abstract 2
- 230000033115 angiogenesis Effects 0.000 abstract 1
- 239000005557 antagonist Substances 0.000 abstract 1
- 150000008378 aryl ethers Chemical class 0.000 abstract 1
- ZRALSGWEFCBTJO-UHFFFAOYSA-N guanidine group Chemical group NC(=N)N ZRALSGWEFCBTJO-UHFFFAOYSA-N 0.000 abstract 1
- 239000003112 inhibitor Substances 0.000 abstract 1
- 102000006495 integrins Human genes 0.000 abstract 1
- 108010044426 integrins Proteins 0.000 abstract 1
- 125000004999 nitroaryl group Chemical group 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
- C07D295/20—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carbonic acid, or sulfur or nitrogen analogues thereof
- C07D295/215—Radicals derived from nitrogen analogues of carbonic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
- C07C235/42—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton
- C07C235/44—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton with carbon atoms of carboxamide groups and singly-bound oxygen atoms bound to carbon atoms of the same non-condensed six-membered aromatic ring
- C07C235/52—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton with carbon atoms of carboxamide groups and singly-bound oxygen atoms bound to carbon atoms of the same non-condensed six-membered aromatic ring having the nitrogen atom of at least one of the carboxamide groups bound to an acyclic carbon atom of a hydrocarbon radical substituted by carboxyl groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C247/00—Compounds containing azido groups
- C07C247/02—Compounds containing azido groups with azido groups bound to acyclic carbon atoms of a carbon skeleton
- C07C247/04—Compounds containing azido groups with azido groups bound to acyclic carbon atoms of a carbon skeleton being saturated
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
- C07C271/06—Esters of carbamic acids
- C07C271/08—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
- C07C271/10—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms
- C07C271/22—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms to carbon atoms of hydrocarbon radicals substituted by carboxyl groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C279/00—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups
- C07C279/04—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of guanidine groups bound to acyclic carbon atoms of a carbon skeleton
- C07C279/08—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of guanidine groups bound to acyclic carbon atoms of a carbon skeleton being further substituted by singly-bound oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
- C07C311/15—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings
- C07C311/16—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the sulfonamide groups bound to hydrogen atoms or to an acyclic carbon atom
- C07C311/19—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the sulfonamide groups bound to hydrogen atoms or to an acyclic carbon atom to an acyclic carbon atom of a hydrocarbon radical substituted by carboxyl groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D233/28—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/44—Nitrogen atoms not forming part of a nitro radical
- C07D233/48—Nitrogen atoms not forming part of a nitro radical with acyclic hydrocarbon or substituted acyclic hydrocarbon radicals, attached to said nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
- C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
- C07D235/06—Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
- C07D235/14—Radicals substituted by nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
- C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
- C07D235/24—Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
- C07D235/30—Nitrogen atoms not forming part of a nitro radical
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
Patente de Invenção: <B>"INIBIDORES DA ANGIOGêNESE"<D>. Os miméticos de RGD, os quais combinam uma porção de nitro-arila com uma estrutura de éter arílico/<244>-aminoácido/guanidina, exibem atividade como antagonistas com relação às diversas integrinas e como inibidores da angiogênese.Invention Patent: <B> "ANGIOGENESIS INHIBITORS" <D>. RGD mimetics, which combine a portion of nitro-aryl with an aryl ether / <244> -amino acid / guanidine structure, exhibit activity as antagonists with respect to the various integrins and as inhibitors of angiogenesis.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US11088598A | 1998-07-06 | 1998-07-06 | |
PCT/US1999/015252 WO2000001383A1 (en) | 1998-07-06 | 1999-07-06 | Angiogenesis inhibitors |
Publications (1)
Publication Number | Publication Date |
---|---|
BR9911885A true BR9911885A (en) | 2001-03-27 |
Family
ID=22335452
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR9911885-8A BR9911885A (en) | 1998-07-06 | 1999-07-06 | Angiogenesis inhibitors |
Country Status (14)
Country | Link |
---|---|
EP (1) | EP1094812A4 (en) |
JP (1) | JP2002519377A (en) |
KR (1) | KR20010079497A (en) |
CN (1) | CN1308534A (en) |
AU (1) | AU4862599A (en) |
BR (1) | BR9911885A (en) |
CA (1) | CA2336774A1 (en) |
HU (1) | HUP0104509A3 (en) |
ID (1) | ID28125A (en) |
NO (1) | NO20010085L (en) |
PL (1) | PL345574A1 (en) |
SK (1) | SK242001A3 (en) |
WO (1) | WO2000001383A1 (en) |
ZA (1) | ZA200007405B (en) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9805655D0 (en) | 1998-03-16 | 1998-05-13 | Celltech Therapeutics Ltd | Chemical compounds |
GB9814414D0 (en) | 1998-07-03 | 1998-09-02 | Celltech Therapeutics Ltd | Chemical compounds |
GB9826174D0 (en) | 1998-11-30 | 1999-01-20 | Celltech Therapeutics Ltd | Chemical compounds |
AU2001248553A1 (en) | 2000-04-17 | 2001-10-30 | Celltech R And D Limited | Enamine derivatives as cell adhesion molecules |
US6486174B2 (en) | 2000-08-07 | 2002-11-26 | 3-Dimensional Pharmaceuticals, Inc. | Tetrahydroisoquinoline-3-carboxylic acid alkoxyguanidines as integrin antagonists |
WO2003079442A1 (en) | 2002-03-20 | 2003-09-25 | Koninklijke Philips Electronics N.V. | Active matrix electroluminescent display devices, and their manufacture |
CA2548243A1 (en) * | 2003-12-03 | 2005-06-23 | The Scripps Research Institute | Integrin aiib.beta.3 specific antibodies and peptides |
EP3381460A4 (en) * | 2015-11-26 | 2019-07-17 | Daiwa Pharmaceutical Co., Ltd | Angiogenesis inhibitor |
CN109535035A (en) * | 2019-01-08 | 2019-03-29 | 吉尔生化(上海)有限公司 | A kind of preparation method of the N- benzyloxycarbonyl group -3- amino-alanine tert-butyl ester |
CN113773260B (en) * | 2021-08-26 | 2023-09-22 | 华南师范大学 | Covalent-like organic material and preparation method and application thereof |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2144763A1 (en) * | 1992-10-14 | 1994-04-28 | George D. Hartman | Fibrinogen receptor antagonists |
WO1994012181A1 (en) * | 1992-12-01 | 1994-06-09 | Merck & Co., Inc. | Fibrinogen receptor antagonists |
AU701776B2 (en) * | 1994-05-27 | 1999-02-04 | Merck & Co., Inc. | Compounds for inhibiting osteoclast-mediated bone resorption |
EP0901373B1 (en) * | 1996-04-10 | 2002-11-06 | Merck & Co., Inc. | Alpha v Beta 3 ANTAGONISTS |
-
1999
- 1999-07-06 SK SK24-2001A patent/SK242001A3/en unknown
- 1999-07-06 EP EP99932289A patent/EP1094812A4/en not_active Withdrawn
- 1999-07-06 CA CA002336774A patent/CA2336774A1/en not_active Abandoned
- 1999-07-06 CN CN99808280A patent/CN1308534A/en active Pending
- 1999-07-06 PL PL99345574A patent/PL345574A1/en not_active Application Discontinuation
- 1999-07-06 KR KR1020017000144A patent/KR20010079497A/en not_active Application Discontinuation
- 1999-07-06 HU HU0104509A patent/HUP0104509A3/en unknown
- 1999-07-06 ID IDW20010172A patent/ID28125A/en unknown
- 1999-07-06 AU AU48625/99A patent/AU4862599A/en not_active Abandoned
- 1999-07-06 WO PCT/US1999/015252 patent/WO2000001383A1/en not_active Application Discontinuation
- 1999-07-06 BR BR9911885-8A patent/BR9911885A/en not_active Application Discontinuation
- 1999-07-06 JP JP2000557829A patent/JP2002519377A/en active Pending
-
2000
- 2000-12-12 ZA ZA200007405A patent/ZA200007405B/en unknown
-
2001
- 2001-01-05 NO NO20010085A patent/NO20010085L/en not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
HUP0104509A3 (en) | 2002-05-28 |
HUP0104509A2 (en) | 2002-04-29 |
ID28125A (en) | 2001-05-03 |
NO20010085L (en) | 2001-03-05 |
JP2002519377A (en) | 2002-07-02 |
SK242001A3 (en) | 2001-10-08 |
CN1308534A (en) | 2001-08-15 |
AU4862599A (en) | 2000-01-24 |
WO2000001383A1 (en) | 2000-01-13 |
PL345574A1 (en) | 2001-12-17 |
ZA200007405B (en) | 2001-09-21 |
KR20010079497A (en) | 2001-08-22 |
EP1094812A4 (en) | 2003-04-16 |
CA2336774A1 (en) | 2000-01-13 |
NO20010085D0 (en) | 2001-01-05 |
EP1094812A1 (en) | 2001-05-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR0111438A (en) | Barbituric acid analogues as therapeutic agents | |
TR200101772T2 (en) | Hydroxy diphenyl urea sulfonamides as IL-8 Receptor antagonists | |
BR9911885A (en) | Angiogenesis inhibitors | |
BR9713338A (en) | Benzonaphyridines as bronchial therapeutics. | |
ES2192301T3 (en) | RESORCINOL DERIVATIVES | |
PT1272161E (en) | Lipid-based drug delivery systems against parasitic infections | |
BR0014214A (en) | Amide substituted imidazoquinolines | |
PT1208086E (en) | FORMULATION OF BENZAMIDE WITH INHIBITOR ACTIVITY OF HISTONE DESACETILASE. | |
BR9808581A (en) | Stabilization of acid-sensitive benzimidazoles with amino acid / cyclodextrin combinations | |
BR0011433A (en) | Imidazoquinolines substituted with sulfonamide and sulfamide | |
ATE245351T1 (en) | ELETROLYTIC SYNTHESIS OF PERACETIC ACID | |
BR0009480A (en) | Polyurethane solutions with alkoxysilane structure units | |
PT1169460E (en) | PREPARATION OF BIOLOGICALLY ACTIVE MOLECULES. | |
BR9901279A (en) | Replaced tricycles | |
BR9808255A (en) | Aminosalicylic acid amides replaced with fungicidal effect and intermediate products for their preparation. | |
BR9811094A (en) | Therapeutic agent for lymphatic tumors | |
BR0209440A (en) | Sulfonamides | |
SE9901077D0 (en) | Novel use | |
BR9916575A (en) | Pharmaceutical composition of controlled release with tilidine mesylate as active substance | |
SV2002000041A (en) | RESORCINOL DERIVATIVES REF. PC10529 / 82897 / BB | |
UY26426A1 (en) | NEW COMPOUNDS | |
BR9809303A (en) | "preservative composition comprising iodopropynyl butyl carbamate and phenoxyethanol" | |
BR0112372A (en) | Non-peptide substituted spirobenzoazepines as vasopressin antagonists | |
BR0009838A (en) | Cyclic pyrrolidinecarbonylamino disulfides | |
BR0115139A (en) | Bisheterocyclic compounds with antitumor and chemosensitizing activity |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FA10 | Dismissal: dismissal - article 33 of industrial property law | ||
B11Y | Definitive dismissal - extension of time limit for request of examination expired [chapter 11.1.1 patent gazette] |